Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2967-2026

Paragonix Technologies Inc. KidneyVault Portable Renal Perfusion System REF# PRGNX-8008-001 Recall

Paragonix Technologies Inc. KidneyVault Portable Renal Perfusion System REF# PRGNX-8008-001

FDA recall Class II

Ongoing

FDA lists this Class II recall for Paragonix Technologies Inc. KidneyVault Portable Renal Perfusion System REF# PRGNX-8008-001. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2967-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jul 20, 2026
FDA report date
Aug 26, 2026
Quantity in commerce
1445 systems
Distribution
See key details
FDA cause
Software design

What is being recalled?

Paragonix Technologies Inc. KidneyVault Portable Renal Perfusion System REF# PRGNX-8008-001

Affected model & UDI checker

Search the exact identifiers published for Z-2967-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
PRGNX-8008-001Paragonix Technologies Inc. KidneyVault Portable Renal Perfusion System REF# PRGNX-8008-001Check source noticeNot specified
Not specifiedParagonix Technologies Inc. KidneyVault Portable Renal Perfusion System REF# PRGNX-8008-001Check source notice00850005470342
FDA code information

All Serial Numbers/UDI: 00850005470342 Software Version: Paragonix App Ver. 6.1.1/6.1.2

View the original FDA recall notice

Why was this product recalled?

Due to a firmware defect, the portable organ transfer device datalogger may lose its configuration, resulting in a blank screen and loss of displayed preservation parameters.

What actions did Paragonix Technologies Inc. take?

On July 20, 2026, Paragonix Technologies Inc./Getinge issued an Urgent Medical Device Correction to affected consignees via FedEX mail. Paragonix requested consignees to take the following actions: 1. An update to the Paragonix App has been released through the application store. 2. We recommend updating all mobile devices to latest version prior to KidneyVault usage. 3. Please continue to inspect all KidneyVault devices per the IFU before use to ensure proper datalogger function. 4. Continue to follow the IFU for using a multi-faceted clinical approach to assessing the organ, including any/all information available on the datalogger screen. 5. Please ensure this message is forwarded to any individuals that need notification within your organization or any organization where the affected devices have been transferred. 6. Complete and return the enclosed response form by e-mailing a copy to [email protected].

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology